Drawing for MGISP

USPTO serial 79307761

MGISP

Reviewed by CopyMark Law Group

Reg. 6726791Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
LAM, HAI-LY HUYNH
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MGISP?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Charles Ho

Charles Ho BYIP LTD.5465 Legacy Drive, Suite 650Plano, TX 75024UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Reagents for use in medical genetic testing; Reagents for gene detection for medical purposes; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of immune system; Chemical reagents for medical or veterinary purposes; Pharmaceutical preparations for treating cancer and genetic diseases; Reagents for gene detection for veterinary purposes; Diagnostic biomarker reagents for medical purposes; Biological preparations for medical purposes, namely, for treating cancer and genetic diseases; Dietetic substances, namely, dietetic confectionery all adapted for medical useACTIVE—
009Nucleic acid sequencers used for analyzing nucleic acids in scientific research; Surveying machines and instruments; Apparatus and measuring instruments for physical and chemical test and composition analysis, namely, electronic analyzers for testing and analyzing chemical and biological substances for the presence, absence, or quantity of target chemicals, biologics and contaminants; Diagnostic apparatus, not for medical purposes, namely, for the detection of pathogens for laboratory or research use; Laboratory equipment, namely, protein sequence analysis apparatus; Data processing apparatus; Laboratory apparatus and instruments, namely, gene analyzers for genome information; Gene amplification instrument for scientific research purposes; DNA microarrays for laboratory use; Computer programs being downloadable software for biological data mining; Computer programs being downloadable software for developing bioinformatics database for others; Computer programs being downloadable software for analyzing genome informationACTIVE—
010Medical apparatus for detecting gene, namely, flow cytometers and flow-based analyzers providing cell and particle analysis and detection for medical use; Apparatus for DNA and RNA testing for medical purposes; Apparatus for use in medical analysis, namely, computerized medical recording and analysis apparatus for the diagnosis and analysis of cancer, genetic diseases and microbial infectious diseases; Apparatus for the regeneration of stem cells for medical purposes; Blood testing apparatus; Diagnostic apparatus for medical purposes, namely, diagnostic apparatus for testing blood sugar levels, cancer cells and DNA; Medical apparatus and instruments, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Medical apparatus and instruments, namely, apparatus for detecting tumor cancer and genetic diseases; Medical apparatus and instruments, namely, apparatus for detecting and treating tumor and cancer; Apparatus for nursing infants, namely, baby nursers, nursing bottles; Radiological apparatus for medical purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 2, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 10, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 9, 2022FIMPFINAL DISPOSITION PROCESSED—
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 15, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 15, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 15, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 1, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 1, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 28, 2022GPNXNOTIFICATION PROCESSED BY IB—
Feb 9, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 9, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 9, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 25, 2022PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 25, 2022ALIEASSIGNED TO LIE—
Jan 25, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Jan 10, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 10, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 10, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 28, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 28, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 28, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 19, 2021RFNTREFUSAL PROCESSED BY IB—
Jun 30, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 30, 2021RFRRREFUSAL PROCESSED BY MPU—
Jun 24, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 23, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 18, 2021DOCKASSIGNED TO EXAMINER—
Apr 9, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Apr 5, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 1, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance